Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,038 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's Lymphoma

NCT00090038

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • USC KECK School of Medicine Los Angeles, California, United States
  • Radiant Research Honolulu, Hawaii, United States
  • Carle Clinic Association Urbana, Illinois, United States
  • Tufts - New England Medical Center Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

NCT00006246

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +57 more
Locations
  • UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Duke Comprehensive Cancer Center Durham, North Carolina, United States
View Trial Details
Completed

Chemotherapy and Radiotherapy for Osteolymphoma

NCT00141648

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +6 more
Locations
  • Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
  • Liverpool Hospital Liverpool, New South Wales, Australia
  • Calvary Mater Newcastle Newcastle, New South Wales, Australia
  • Westmead Hospital Wentworthville, New South Wales, Australia
View all 20 locations
View Trial Details
Completed

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

NCT00220766

Conditions
Agammaglobulinemia, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +24 more
Locations
  • Departments of Medicine and Microbiology Birmingham, Alabama, United States
  • National Jewish Medical and Researach Center Denver, Colorado, United States
  • International Center for Interdisciplinary Studies of Immunology Washington D.C., District of Columbia, United States
  • Allergy Associates of the Palm Beaches North Palm Beach, Florida, United States
View all 13 locations
View Trial Details
Completed

Phase I, Multi-Center, Open-Label, Dose Escalation Study of HuLuc63 in Subjects With Advanced Multiple Myeloma

NCT00425347

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Arkansas Cancer Research Center Little Rock, Arkansas, United States
  • USC/Norris Cancer Hospital Los Angeles, California, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details

Related conditions